de Bree R - Search Results

1

Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experience.

de Bree R, van der Valk P, Kuik DJ, van Diest PJ, Doornaert P, Buter J, Eerenstein SE, Langendijk JA, van der Waal I, Leemans CR. de Bree R, et al. Oral Oncol. 2006 Aug;42(7):703-9. doi: 10.1016/j.oraloncology.2005.11.009. Epub 2006 Mar 10. Oral Oncol. 2006. PMID: 16529978

2

Clinical screening of monoclonal antibodies 323/A3, cSF-25 and K928 for suitability of targetting tumours in the upper aerodigestive and respiratory tract.

De Bree R, Roos JC, Quak JJ, Den Hollander W, Snow GB, Van Dongen GA. De Bree R, et al. Nucl Med Commun. 1994 Aug;15(8):613-27. doi: 10.1097/00006231-199408000-00006. Nucl Med Commun. 1994. PMID: 7970443 Clinical Trial.

3

Perspectives of monoclonal antibodies for detection and treatment of head and neck tumours.

Quak J, Gerretsen M, De Bree R, Brakenhof R, Van Dongen G, Snow G. Quak J, et al. Among authors: de bree r. Anticancer Res. 1993 Nov-Dec;13(6B):2533-9. Anticancer Res. 1993. PMID: 8135493

4

Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2.

de Bree R, Roos JC, Quak JJ, den Hollander W, van den Brekel MW, van der Wal JE, Tobi H, Snow GB, van Dongen GA. de Bree R, et al. J Nucl Med. 1994 May;35(5):775-83. J Nucl Med. 1994. PMID: 8176458 Free article.

5

Malignant lymphoma of mucosa-associated lymphoid tissue in the larynx.

de Bree R, Mahieu HF, Ossenkoppele GJ, van der Valk P. de Bree R, et al. Eur Arch Otorhinolaryngol. 1998;255(7):368-70. doi: 10.1007/s004050050079. Eur Arch Otorhinolaryngol. 1998. PMID: 9783135

6

The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patients.

de Bree R, Kuik DJ, Quak JJ, Roos JC, van den Brekel MW, Castelijns JA, van Wagtendonk FW, Greuter H, Snow GB, van Dongen GA. de Bree R, et al. Eur J Nucl Med. 1998 Nov;25(11):1562-5. doi: 10.1007/s002590050336. Eur J Nucl Med. 1998. PMID: 9799354 Clinical Trial.

7

Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.

de Bree R, Roos JC, Quak JJ, den Hollander W, Wilhelm AJ, van Lingen A, Snow GB, Dongen GA. de Bree R, et al. Clin Cancer Res. 1995 Mar;1(3):277-86. Clin Cancer Res. 1995. PMID: 9815983

8

Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.

de Bree R, Roos JC, Quak JJ, den Hollander W, Snow GB, van Dongen GA. de Bree R, et al. Clin Cancer Res. 1995 Jun;1(6):591-8. Clin Cancer Res. 1995. PMID: 9816020

9

Screening for distant metastases in patients with head and neck cancer.

de Bree R, Deurloo EE, Snow GB, Leemans CR. de Bree R, et al. Laryngoscope. 2000 Mar;110(3 Pt 1):397-401. doi: 10.1097/00005537-200003000-00012. Laryngoscope. 2000. PMID: 10718426

10

Intracranial metastases in patients with squamous cell carcinoma of the head and neck.

de Bree R, Mehta DM, Snow GB, Quak JJ. de Bree R, et al. Otolaryngol Head Neck Surg. 2001 Feb;124(2):217-21. doi: 10.1067/mhn.2001.112478. Otolaryngol Head Neck Surg. 2001. PMID: 11226960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

510 results

Search Page

Filters